Tumor‐associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma
The Journal of Pathology: Clinical Research · 2025
DOI: 10.1002/2056-4538.70038 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, 2025. Verfasst von Maja Dam Andersen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Hodgkin Disease, Tumor-Associated Macrophages, Bone Neoplasms, Macrophages. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Carl og Ellen Hertz fonden, Torben og Alice Frimodts Fond, Danish Lymphoma Group.
Abstract (Originalsprache)
The biology of tumor spread to bone is poorly understood, not least in classic Hodgkin lymphoma (cHL). We used gene expression profiling and immunohistochemistry to characterize the nodal tumor microenvironment of cHL cases with and without skeletal involvement at diagnosis. Gene expression profiling of 66 pretreatment lymphoma samples revealed that lymph nodes from patients with skeletal cHL (s‐cHL) exhibited a higher abundance of cells expressing macrophage markers, particularly M2‐like markers, than nodal‐only cHL (n‐cHL). These markers included CD163 , MRC1 ( CD206 ), MARCO , and SIGLEC1 . Additionally, there was a notable downregulation of genes encoding B‐cell‐associated markers such as MS4A1 ( CD20 ), CD19 , PAX5 , and CD79A/B . We further evaluated the protein expression of macrophage markers (CD68, CD163, and CD206) and the B‐cell marker CD20 in 193 pretreatment lymphoma samples using immunohistochemistry. Our analysis revealed significantly higher expression levels of all three macrophage markers in s‐cHL samples compared to n‐cHL samples ( p < 0.001). Conversely, the expression level of CD20 was significantly lower in s‐cHL compared with n‐cHL ( p < 0.001). All three macrophage markers correlated positively with Ann Arbor stage, indicating their potential involvement in the dissemination of cHL in general. Our findings suggest a potential role for tumor‐associated macrophages in the dissemination of cHL to bone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark.
- Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Medicine, Regional Hospital Goedstrup, Herning, Denmark.
ORCID-Profile: Maja Dam Andersen
Förderung
- Carl og Ellen Hertz fonden
- Torben og Alice Frimodts Fond
- Danish Lymphoma Group
- Kong Christian den Tiendes Fond
- Institut for Klinisk Medicin, Aarhus Universitet
- Health Research Foundation of Central Denmark Region
- Aase og Ejnar Danielsens Fond
- Eva og Henry Frænkels Mindefond
Zitieren
APA
Andersen, M. D., Wolter, K., Enemark, M. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M., & Kamper, P. (2025). Tumor‐associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.70038
Vancouver
Andersen MD, Wolter K, Enemark MH, Pedersen MA, Gormsen LC, Lauridsen KL, et al. Tumor‐associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma. The Journal of Pathology: Clinical Research. 2025. doi:10.1002/2056-4538.70038
BibTeX
@article{Andersen2025,
author = {Andersen, Maja Dam and Wolter, Katharina and Enemark, Marie Hairing and Pedersen, Mette Abildgaard and Gormsen, Lars Christian and Lauridsen, Kristina Lystlund and Starklint, Jørn and Hamilton-Dutoit, Stephen Jacques and d'Amore, Francesco and Ludvigsen, Maja and Kamper, Peter},
title = {Tumor‐associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma},
journal = {The Journal of Pathology: Clinical Research},
year = {2025},
doi = {10.1002/2056-4538.70038}
}
EUVIMED